HTA requirements and evidence standards vary by country and evolve quickly, turning market access expansion into a moving target.
Bridging an HTA dossier across markets is no longer just reformatting: it requires re-validating claims, aligning to local methodological expectations, and updating comparators, endpoints, and value narratives.
With evidence scattered across clinical, HEOR, RWE, and prior submissions, maintaining consistency, traceability, and speed across adaptations is a major challenge.
6× faster country adaptations
Accelerate HTA dossier bridging across markets by automating requirement mapping, gap analysis, and localized drafting from a shared evidence base.
Lower appraisal back-and-forth
Align to local HTA expectations upfront with consistent, evidence-linked narratives — reducing rework, clarifications, and late-stage rewrites.
Stronger, traceable value story
Maintain defensible claims with source-linked evidence and a full run record, improving internal review confidence and payer-facing credibility.
How it works
1
Assemble the HTA reference corpus — centralize country-specific HTA methods, submission templates, and payer expectations (HAS, NICE, G-BA, etc.) as a governed, versioned baseline.
2
Define the bridging context — select target countries, indication, comparators, population, outcomes, and evidence sources; Biolevate builds an “applicability map” of what changes market-to-market.
3
Run an exhaustive gap & adaptation analysis — compare the source dossier against each country’s requirements to identify missing sections, required reframing, evidence gaps, and local appendix needs with full traceability.
4
Generate guided rewrites and localized drafts — produce country-aligned updates (value story, clinical evidence narrative, economic sections, evidence tables) with source-linked claims and a run record for review and reuse.
Country-level applicability + run record: map HTA requirements to dossier sections and track every change with auditable run records.
Evidence-linked generation: keep narratives grounded in the underlying evidence base (SLR, RWE, HEOR) to defend claims during appraisal.